Data Factory
Reading the graph
Reading the graph
Private Equity
San Francisco, CA
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| 5am Opportunities II, LP | 2022 | Early deployment | Private Equity Fund | n/a | $320M | 0 |
| 5am Opportunities I, LP | 2019 | Harvest | Private Equity Fund | n/a | $67.8M | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Scientist.com | n/a | unknown | unknown | Jan 1, 2025 | n/a | unknown |
| scPharmaceuticals | n/a | unknown | unknown | Jan 1, 2025 | n/a | unknown |
| Escient | n/a | unknown | unknown | Jan 1, 2024 | n/a | unknown |
| Bird Rock Bio | n/a | unknown | unknown | Jan 1, 2023 | n/a | exited |
| CinCor Pharma | n/a | unknown | unknown | Jan 1, 2023 | n/a | exited |
| Akouos | n/a | unknown | unknown | Jan 1, 2022 | n/a | unknown |
| Purigen Biosystems | n/a | unknown | unknown | Jan 1, 2022 | n/a | exited |
| Precision NanoSystems | n/a | unknown | unknown | Jan 1, 2021 | n/a | exited |
| Audentes | n/a | unknown | unknown | Jan 1, 2019 | n/a | exited |
| Ceterix Orthopedics | n/a | unknown | unknown | Jan 1, 2018 | n/a | unknown |
| Ambrx | n/a | unknown | unknown | Jan 1, 2015 | n/a | unknown |
| Calibrium | n/a | unknown | unknown | Jan 1, 2015 | n/a | exited |
| Cellular Research | n/a | unknown | unknown | Jan 1, 2015 | n/a | exited |
| Novira | n/a | unknown | unknown | Jan 1, 2015 | n/a | exited |
| DVS Sciences | n/a | unknown | unknown | Jan 1, 2014 | n/a | exited |
| Ikaria | n/a | unknown | unknown | Jan 1, 2014 | n/a | exited |
| Incline | n/a | unknown | unknown | Jan 1, 2013 | n/a | exited |
| Pearl | n/a | unknown | unknown | Jan 1, 2013 | n/a | exited |
| Envoy | n/a | unknown | unknown | Jan 1, 2012 | n/a | exited |
| Semprus Biosciences | n/a | unknown | unknown | Jan 1, 2012 | n/a | exited |
| Synosia | n/a | unknown | unknown | Jan 1, 2011 | n/a | exited |
| Marcadia | n/a | unknown | unknown | Jan 1, 2010 | n/a | exited |
| Panomics | n/a | unknown | unknown | Jan 1, 2008 | n/a | exited |
| Ilypsa | n/a | unknown | unknown | Jan 1, 2007 | n/a | exited |
| Miikana | n/a | unknown | unknown | Jan 1, 2006 | n/a | exited |
| Achaogen | n/a | unknown | unknown | n/a | n/a | unknown |
| Alexza | n/a | unknown | unknown | n/a | n/a | unknown |
| Aprea | n/a | unknown | unknown | n/a | n/a | unknown |
| Artiva | n/a | unknown | unknown | n/a | n/a | unknown |
| Arvinas | n/a | unknown | unknown | n/a | n/a | unknown |
Also named here, with no published line of their own (reach them through the firm): Jennifer Zimmermann (Marketing Manager & Executive Assistant), Katie Wolfe (Executive Assistant), Jami Wiegand (Senior Manager, Information Technology), Jonathan Weissman (PhD Venture Advisor), Alex Wareham (Management Company Controller), Joseph J. Victor (Venture Advisor), Arthur Tzianabos (PhD Venture Partner), Aniqa Tasnim (PhD Senior Associate), Paul a Stone (JD Legal Advisor), Katie Bodner Spielberg (PhD Principal), Paula Soteropoulos (Venture Advisor), Luke Serra (CPA Assistant Controller).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan